Ryde4Life Program
We are sharing this information from the Department of Human Services Division of Senior Services One Bergen County Plaza Hackensack, New Jersey 07601 17_0329_Ryde4Life Program Brochure
Categories: Breaking News
Posts belonging to Category Breaking News
2017 Medical Scholarship
Application available by clicking on the link above or the “Scholarships” tab at the top of this page.
Categories: Breaking News
ME and the PACE trial in the New York Times
David Tuller and Julie Rehmeyer have published an article in the New York Times about ME and the PACE trial. https://www.nytimes.com/2017/03/18/opinion/sunday/getting-it-wrong-on-chronic-fatigue-syndrome.html?smid=tw-share&_r=0
Categories: Breaking News
#GivingTuesday
This is the season of giving. Tuesday is National Day of Giving! Be a part of #GivingTuesday – DONATE to NJME/CFSA! NJ/MECFSA is a 501(c)(3) non-profit organization. DONATE at http://www.njcfsa.org/donate/ If you prefer there is also https://www.gofundme.com/ArpitaSheth-MyME (funds also go directly to the organization
Categories: Breaking News
Scholarships
The 2016 Scholarships have been posted. Click on the “Scholarships” tab above. The Medical Scholarship winner and runner-up essays are at that site.
Categories: Breaking News
Info from Bateman Horne Center
Simple Way to Assess Orthostatic Intolerance
Categories: Breaking News, Resources
Gene Study
Dr. Nancy Klimas’ ME/CFS Gene Study at Nova Southeast University is still seeking patient and healthy volunteers. If you are interested, you can send a message to Helpdesk@njmecfsa.org and we will forward it to the study. More information can be found at https://sharkmedia.nova.edu/m…/ME+CFS+Genes+Study/1_06vh90p0 This is a chance for both patients and healthy volunteers to participate.
Categories: Breaking News
Follow-Up to Letter to NIH Director Collins
Read about the encouraging results at: http://www.meaction.net/2016/09/09/members-of-congress-urge-nih-director-francis-collins-to-strengthen-biomedical-research-into-myalgic-encephalomyelitis-chronic-fatigue-syndrome/
Categories: Breaking News
First Approved ME/CFS Treatment in the World
Hemispherx Biopharma Announces Major Breakthrough: Approval for Commercial Sale of Rintatolimod (U.S. Tradename: Ampligen®) to Treat Severe Cases of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) in the Argentine Republic First Product Approved for ME/CFS Indication Anywhere in the World. Ampligen Approved in Argentina – First in the World 2016-08-23
Categories: Breaking News
2016 Membership Renewal
August is Membership Renewal Month Please support the work of NJME/CFSA. See information at the link below. 2016-08 Membership Renewal Request
Categories: Breaking News